Drug selection in the treatment of Hodgkin's disease
โ Scribed by Gianni Bonadonna; Armando Santoro
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 801 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0278-0232
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Between January, 1975, and December, 1978, 118 patients with advanced Hodgkin's disease were treated with 8 months of alternating MOPP and adriamycin, bleomycin, dacarbazine and vinblastine (ABDV) combined with 1 month of low-dose radiation therapy (2,000 rad) to areas initially involved with bulky
In 35 cases of advanced Hodgkin's disease (stage IIIB to IVB), of whom 33 were no longer responsive to the alkylating agents, vinblastine produced clinically useful remissions in 22 patients or 64%. Complete objective responses were unusual but one third of these cases experienced partial remissions